PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsThrombasthenia
MeSH D013915 - thrombasthenia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D025861:Inherited blood coagulation disorders
$
Success rate
D006474:Hemorrhagic disorders
$
Success rate
D001791:Blood platelet disorders
0 Companies
0 Drugs
Success rate
D013915: 
Thrombasthenia
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Novo NordiskEptacog alfa (activated) NovoSeven  1996-02-23   
Clinical Trials
Historical Success Rate
Phase 1
33%
1/3
Phase 2
0%
0/8
Phase 3
100%
1/1
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novo Nordisk
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use